chartexchange

AXIM
AXIM BIOTECHNOLOGIES INC
stockOTC

EODNov 16, 2026
0.0031USD-1.274%(-0.00)12,062
Loading…
Loading…
912,822
Healthcare
Biotechnology
HQ
San Diego, CA, USA
Previous Close
$0.00
Beta
0.10
52-Week High
$0.03 2025-12-03
52-Week Low
$0.00 2026-04-30
SMA 50
$0.00
SMA 200
$0.01
Avg. Vol 10D
237,747
Avg. Vol 30D
170,016
Avg. Vol 90D
334,902
Relative Vol
0.07
294.46M
243.75M
5,639
AXIM Profile

axim biotechnologies, inc. is a vertically integrated research and development company focused on changing diagnosis and treatment for oncology and sars-cov-2 (covid-19). the company's neucovix is the rapid diagnostic test measuring levels of functional neutralizing antibodies that are believed to prevent sars-cov-2 from entering the host cells. it is developing rapid diagnostic tests for the early detection of cancer and proprietary small molecules drugs to treat cancer and block metastasis. the company was formerly known as axim international inc. and changed its name to axim biotechnologies, inc. in july 2014. axim biotechnologies, inc. was founded in 2010 and is headquartered in san diego, california.

AXIM Performance
PeriodPriceDateChangeBeta
1W0.002026-11-10-3.13%-0.605
1M0.002026-10-19+1.31%-0.066
3M0.002026-08-17-32.61%-0.177
6M0.012026-05-18-40.38%0.545
1Y0.012025-11-17-76.55%0.105
2Y0.002024-11-18-2.82%—
5Y0.432021-11-17-99.28%-0.065
AXIM Stock Summary

AXIM BIOTECHNOLOGIES INC (OTC:AXIM) stock price today is $0.00, and today's volume is 12,062. AXIM is down 1.274% today. The 30 day average volume is 170,016. AXIM market cap is $912,822 with 294.46M shares outstanding.